About Ajay Wakhloo
Ajay Wakhloo is a chief executive officer and director at NeuroFine.
Form D filings also name Ajay Wakhloo as CEO and director at Prometheus Therapeutics and a director at Deinde Medical.
Ajay Wakhloo first appears on SEC filings in 2019.
Experience
This experience comes from Ajay Wakhloo's profile and from SEC filings. For roles taken from filings, the years are when the filings name Ajay Wakhloo in the role, so the role may have started earlier or lasted longer.
NeuroFine Corp. Current
Chief Executive Officer&President (2025 – Present)
Director
2021 – Present · Miramar, FL
Prometheus Therapeutics Inc. Current
Chief Executive Officer (2023 – Present)
Director
2020 – Present · Miramar, FL
Develops light-based treatment technology for people with vascular diseases, including brain aneurysms.
TM
Tufts University School of Medicine Current
Professor Tufts University School of Medicine
2018 – Present
BH
Beth Israel Lahey Health
Divison Chief, Department of Neurointerventional Radiology
2018 – 2023
US
University of Massachusetts Medical School
Chief & Professor Neuroimaging and Intervention, Dept Radiology, Director for Stroke Research
2005 – 2018
UM
University of Miami, Miller School of Medicine
Professor and Chief, Neurointerventional Radiology, Dept. of Radiology
1999 – 2005
UB
University at Buffalo
Associate Professor
1997 – 1999
Key Colleagues at Startups
The people Ajay Wakhloo works with at each company, as listed on that company's latest Form D.
Prometheus Therapeutics Inc. · Form D/A, Apr 15, 2026
AH
Alexander Hastings
Director
BN
Bernie Navarro
Executive officer
Baruch Lieber
President & CSO, director
JM
John McEleney
Director
NeuroFine Corp. · Form D, Apr 8, 2026
JM
John McEleney
Director
DS
Daniel Sablyak
Director
BN
Bernie Navarro
Executive officer
ML
Marc Litzenberg
Director
Deinde Medical Corp. · Form D, Nov 12, 2025
BN
Bernie Navarro
Executive officer
PL
Prattipati Laxminarain
Director
ML
Marc Litzenberg
Chief Executive Officer and director
JM
John McEleney
Director